{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:05:58Z","timestamp":1790064358017,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001717","name":"Leiden University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024872","name":"Toegepaste en Technische Wetenschappen, NWO","doi-asserted-by":"publisher","award":["19532"],"award-info":[{"award-number":["19532"]}],"id":[{"id":"10.13039\/501100024872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.mtbio.2026.103103","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T01:24:29Z","timestamp":1775438669000},"page":"103103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Vaccination with cationic liposome-encapsulated CD4 and CD8 T cell neoepitopes induces superior tumor control"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7269-8346","authenticated-orcid":false,"given":"Felicia S.","family":"Spitzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Heuts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1158-5142","authenticated-orcid":false,"given":"Brett J.","family":"Hos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Romeijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel G.M.","family":"Camps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferry","family":"Ossendorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0682-2403","authenticated-orcid":false,"given":"Koen","family":"van der Maaden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2026.103103_bib1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.mtbio.2026.103103_bib2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41568-025-00820-z","article-title":"Recent advances in therapeutic cancer vaccines","volume":"25","author":"Zaidi","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2026.103103_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.mtbio.2026.103103_bib4","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.aar7112","article-title":"Personalized vaccines for cancer immunotherapy","volume":"359","author":"Sahin","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.mtbio.2026.103103_bib5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41423-025-01316-4","article-title":"Eliciting antitumor immunity via therapeutic cancer vaccines","volume":"22","author":"Peng","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.mtbio.2026.103103_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.103103_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.103103_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005016","article-title":"Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions","volume":"10","author":"Speetjens","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mtbio.2026.103103_bib9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrd2224","article-title":"More than one reason to rethink the use of peptides in vaccine design","volume":"6","author":"Purcell","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2026.103103_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.696791","article-title":"Beyond just peptide antigens: the complex world of peptide-based cancer vaccines","volume":"12","author":"Stephens","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2026.103103_bib11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1158\/2326-6066.CIR-16-0283","article-title":"Efficient eradication of established tumors in mice with cationic liposome-based synthetic long-peptide vaccines","volume":"5","author":"Varypataki","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.mtbio.2026.103103_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11095-018-2490-6","article-title":"Cationic liposomes: a flexible vaccine delivery system for physicochemically diverse antigenic peptides","volume":"35","author":"Heuts","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.mtbio.2026.103103_bib13","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1158\/1078-0432.CCR-12-2189","article-title":"Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients","volume":"18","author":"Sabbatini","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103103_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s40425-018-0455-2","article-title":"Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication","volume":"6","author":"Zom","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mtbio.2026.103103_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.990877","article-title":"Effectiveness of combination therapy with ISA101 vaccine for the treatment of human papillomavirus-induced cervical cancer","volume":"12","author":"Ding","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mtbio.2026.103103_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13025","article-title":"Peptide-based therapeutic cancer vaccine: current trends in clinical application","volume":"54","author":"Liu","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.mtbio.2026.103103_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/21645515.2015.1071455","article-title":"Safety and tolerability evaluation of the use of Montanide ISA51 as vaccine adjuvant: a systematic review","volume":"12","author":"van Doorn","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.mtbio.2026.103103_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jconrel.2017.11.035","article-title":"Hollow microneedle-mediated micro-injections of a liposomal HPV E7(43-63) synthetic long peptide vaccine for efficient induction of cytotoxic and T-helper responses","volume":"269","author":"van der Maaden","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103103_bib19","doi-asserted-by":"crossref","first-page":"70317","DOI":"10.18632\/oncotarget.19688","article-title":"Effective antitumor peptide vaccines can induce severe autoimmune pathology","volume":"8","author":"Sultan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.mtbio.2026.103103_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012217","article-title":"Shared epitopes create safety and efficacy concerns in several cancer vaccines","volume":"13","author":"Kellermann","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mtbio.2026.103103_bib21","article-title":"Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancer","volume":"9","author":"Hos","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.mtbio.2026.103103_bib22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune responses to cancer","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.103103_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111680","article-title":"Cancer-specific T helper shared and neo-epitopes uncovered by expression of the MHC class II master regulator CIITA","volume":"41","author":"Hos","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.mtbio.2026.103103_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1102282","article-title":"MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression","volume":"14","author":"Schrors","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2026.103103_bib25","article-title":"Neoantigen-specific T cell help outperforms non-specific help in multi-antigen DNA vaccination against cancer","volume":"32","author":"de Graaf","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.mtbio.2026.103103_bib26","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nature14001","article-title":"Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing","volume":"515","author":"Yadav","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.103103_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.it.2024.02.005","article-title":"Regulation and impact of tumor-specific CD4(+) T cells in cancer and immunotherapy","volume":"45","author":"Guo","year":"2024","journal-title":"Trends Immunol."},{"key":"10.1016\/j.mtbio.2026.103103_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164258","article-title":"Linked CD4+\/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression","volume":"133","author":"Dolina","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.mtbio.2026.103103_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004022","article-title":"CD4(+) T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1\/PD-L1 immunotherapy","volume":"10","author":"Xiao","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mtbio.2026.103103_bib30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1084\/jem.187.5.693","article-title":"Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors","volume":"187","author":"Ossendorp","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mtbio.2026.103103_bib31","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.4049\/jimmunol.176.12.7335","article-title":"Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes","volume":"176","author":"Zaks","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.mtbio.2026.103103_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13050596","article-title":"Cationic nanoparticle-based cancer vaccines","volume":"13","author":"Heuts","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2026.103103_bib33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1208\/s12248-014-9686-4","article-title":"Cationic liposomes loaded with a synthetic long peptide and poly(I:C): a defined adjuvanted vaccine for induction of antigen-specific T cell cytotoxicity","volume":"17","author":"Varypataki","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.mtbio.2026.103103_bib34","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1016\/j.vaccine.2014.05.050","article-title":"Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant","volume":"32","author":"Korsholm","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.mtbio.2026.103103_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics8010007","article-title":"Liposome-based adjuvants for subunit vaccines: formulation strategies for subunit antigens and immunostimulators","volume":"8","author":"Tandrup Schmidt","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2026.103103_bib36","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41587-019-0390-x","article-title":"Peptide-TLR-7\/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens","volume":"38","author":"Lynn","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mtbio.2026.103103_bib37","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.2147\/IJN.S140591","article-title":"Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma","volume":"12","author":"Kuai","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2026.103103_bib38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nmat4822","article-title":"Designer vaccine nanodiscs for personalized cancer immunotherapy","volume":"16","author":"Kuai","year":"2017","journal-title":"Nat. Mater."},{"key":"10.1016\/j.mtbio.2026.103103_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124507","article-title":"Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy","volume":"3","author":"Fransen","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.mtbio.2026.103103_bib40","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1038\/s41598-022-07153-z","article-title":"Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment","volume":"12","author":"Jin","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mtbio.2026.103103_bib41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-022-01247-x","article-title":"Cancer vaccines as promising immuno-therapeutics: platforms and current progress","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mtbio.2026.103103_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00262-025-03992-7","article-title":"Neoantigen-based mRNA vaccine exhibits superior anti-tumor activity compared to synthetic long peptides in an in vivo lung carcinoma model","volume":"74","author":"Nguyen","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.mtbio.2026.103103_bib43","doi-asserted-by":"crossref","first-page":"eadn9961","DOI":"10.1126\/sciadv.adn9961","article-title":"Lipopolyplex-formulated mRNA cancer vaccine elicits strong neoantigen-specific T cell responses and antitumor activity","volume":"10","author":"Fan","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2026.103103_bib44","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.103103_bib45","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41586-024-08508-4","article-title":"RNA neoantigen vaccines prime long-lived CD8(+) T cells in pancreatic cancer","volume":"639","author":"Sethna","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.103103_bib46","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.4049\/jimmunol.1600965","article-title":"Low antigen dose in adjuvant-based vaccination selectively induces CD4 T cells with enhanced functional avidity and protective efficacy","volume":"198","author":"Billeskov","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.mtbio.2026.103103_bib47","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41586-024-07752-y","article-title":"Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy","volume":"632","author":"Sultan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.103103_bib48","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1002\/eji.201444477","article-title":"Concurrent interaction of DCs with CD4(+) and CD8(+) T cells improves secondary CTL expansion: it takes three to tango","volume":"44","author":"Hoyer","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.mtbio.2026.103103_bib49","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.4049\/jimmunol.1401571","article-title":"CD4+ T cell help selectively enhances high-avidity tumor antigen-specific CD8+ T cells","volume":"195","author":"Zhu","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.mtbio.2026.103103_bib50","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.xphs.2022.01.021","article-title":"Quantification of lipid and peptide content in antigenic peptide-loaded liposome formulations by reversed-phase UPLC using UV absorbance and evaporative light scattering detection","volume":"111","author":"Heuts","year":"2022","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.mtbio.2026.103103_bib51","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1084\/jem.185.2.317","article-title":"Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures","volume":"185","author":"Winzler","year":"1997","journal-title":"J. Exp. Med."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426003467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426003467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:39:46Z","timestamp":1790062786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426003467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":51,"alternative-id":["S2590006426003467"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103103","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination with cationic liposome-encapsulated CD4 and CD8 T cell neoepitopes induces superior tumor control","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103103"}}